6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide

C19H19Cl2N7O — CID 163769057

IUPAC6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide
SMILESNC(=O)c1nc(N2[C@@H]3CC[C@H]2CC(N)C3)nc2n[nH]c(-c3cccc(Cl)c3Cl)c12
InChIInChI=1S/C19H19Cl2N7O/c20-12-3-1-2-11(14(12)21)15-13-16(17(23)29)24-19(25-18(13)27-26-15)28-9-4-5-10(28)7-8(22)6-9/h1-3,8-10H,4-7,22H2,(H2,23,29)(H,24,25,26,27)/t8?,9-,10+
InChIKeyMEVROBNDHMNTIB-PBINXNQUSA-N
MW432.32 g/mol
LogP2.88
Rot. Bonds3

About 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide

6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide (PubChem CID 163769057) has the molecular formula C19H19Cl2N7O and a molecular weight of 432.32 g/mol. Its IUPAC name is 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide.

Molecular Properties

Compound Name6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide
PubChem CID163769057
Molecular FormulaC19H19Cl2N7O
Molecular Weight432.32 g/mol
Exact Mass431.10
IUPAC Name6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide
SMILESNC(=O)c1nc(N2[C@@H]3CC[C@H]2CC(N)C3)nc2n[nH]c(-c3cccc(Cl)c3Cl)c12
InChIInChI=1S/C19H19Cl2N7O/c20-12-3-1-2-11(14(12)21)15-13-16(17(23)29)24-19(25-18(13)27-26-15)28-9-4-5-10(28)7-8(22)6-9/h1-3,8-10H,4-7,22H2,(H2,23,29)(H,24,25,26,27)/t8?,9-,10+
InChIKeyMEVROBNDHMNTIB-PBINXNQUSA-N
XLogP2.88
TPSA126.81 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms29
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500432.32
LogP ≤ 52.88
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide?
The IUPAC name of 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide (CID 163769057) is 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide.
What is the SMILES notation for 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide?
The canonical SMILES for 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide is NC(=O)c1nc(N2[C@@H]3CC[C@H]2CC(N)C3)nc2n[nH]c(-c3cccc(Cl)c3Cl)c12.
What is the InChIKey of 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide?
The InChIKey is MEVROBNDHMNTIB-PBINXNQUSA-N. The full InChI is InChI=1S/C19H19Cl2N7O/c20-12-3-1-2-11(14(12)21)15-13-16(17(23)29)24-19(25-18(13)27-26-15)28-9-4-5-10(28)7-8(22)6-9/h1-3,8-10H,4-7,22H2,(H2,23,29)(H,24,25,26,27)/t8?,9-,10+.
What are the key properties of 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide?
6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide has a molecular weight of 432.32 g/mol, XLogP of 2.88, 3 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[(1R,5S)-3-amino-8-azabicyclo[3.2.1]octan-8-yl]-3-(2,3-dichlorophenyl)-2H-pyrazolo[3,4-d]pyrimidine-4-carboxamide is sourced from PubChem (CID 163769057), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).